The Persistence of Neutralising Antibodies up to 11 months after SARS-CoV-2 Infection in the Southern Region of New Zealand
McGregor, R.; Craigie, A. K.; Jack, S.; Upton, A.; Moreland, N. J.; Ussher, J.
Show abstract
During the first wave of SARS-CoV-2 infection in New Zealand a cohort of 78 PCR-confirmed COVID-19 cases was recruited in the Southern District Health Board region. Here we report on this unique cohort nearly 1-year after infection. There was no known community transmission in the region over the study period due to New Zealands elimination status at the time, nor had any participants received a COVID-19 vaccine. In the absence of re-exposure, antibody reactivity to the viral spike protein, as well as neutralising antibodies to both the ancestral strain and the delta variant remained relatively stable between 8 and 11 months post-infection. This suggests long-lived antibody responses can be generated from a single natural infection event. However, given the risks of serious disease associated with SARS-CoV-2 infection, vaccination is still strongly recommended.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Pre-pandemic SARS-CoV-2 serological reactivity in rural malaria-experienced Cambodians 93%
- Early SARS-CoV-2 reinfections within 60 days highlight the need to consider antigenic variations together with duration of immunity in defining retesting policies 93%
- Durability of antibody responses and frequency of clinical and subclinical SARS-CoV-2 infection six months after BNT162b2 COVID-19 vaccination in healthcare workers 93%
Similar papers in this journal
Similar papers in this journal
- SARS-CoV-2 evolution and patient immunological history shape the breadth and potency of antibody-mediated immunity 94%
- SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali 93%
- SARS-CoV-2 specific memory B-cells from individuals with diverse disease severities recognize SARS-CoV-2 variants of concern. 93%
Similar papers in this journal
- Validity of self-testing at home with rapid SARS-CoV-2 antibody detection by lateral flow immunoassay 96%
- Immunogenicity of SARS-CoV-2 infection and Ad26.CoV2.S vaccination in people living with HIV 95%
- Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals 94%
Similar papers in this journal
- Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: active prospective surveillance, December 2020 to March 2021, England 92%
- Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later 91%
- Quantification and prognostic significance of interferon-γ secreting SARS-CoV-2 responsive T cells in hospitalised patients with acute COVID-19 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.